Day One Biopharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:DAWN) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities -50.75 M30.01 M59 M24.81 M5.8 M14.15 M 103.76 M Cash from investing activities -67.7 M192.35 M32.61 M-26.32 M878 K167.48 M 174.65 M Cash from financing activities 200.09 M1.85 M0748 K0471 K 1.22 M Free cash flow -51.48 M28.59 M55.18 M24.8 M5.8 M14.15 M 99.94 M

ニュース

Needham、コスト増を理由にDay One Biopharmaceuticalsの目標株価を引き下げ

Needham lowers Day One Biopharmaceuticals price target on costs

H.C. Wainwrightが Day One Biopharmaceuticalsの目標株価を22ドルに引き下げ

H.C. Wainwright lowers Day One Biopharmaceuticals price target to $22

Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call Transcript

Day One Biopharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:DAWN) 2026-02-25

【決算速報】Day One Biopharmaceuticals、売上高は予想を上回り、利益は予想を下回る結果に

Day One Biopharmaceuticals earnings missed by $0.02, revenue topped estimates

Day One Biopharmaceuticalsが売上高予想を上回る

Day One Biopharmaceuticals beats revenue estimates

Mersana買収後のDay One Biopharmaceuticals決算発表が迫る

Day one Biopharma CCO sold $67k in DAWN stock